Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Indian J Biochem Biophys ; 2008 Aug; 45(4): 219-28
Article in English | IMSEAR | ID: sea-28209

ABSTRACT

Annual deaths in infants and young children due to rotavirus (RV) infection are around 100,000 in India and about 600,000 globally. Development of a vaccine for this disease is a high priority. The protective mechanisms for RV diarrhea in human are not fully understood, but it is known that children develop natural immunity against RV. Early exposure to RV results in most severe episode of diarrhea and subsequent infections are milder or asymptomatic. Of the immune responses measured during natural infection, RV-specific antibodies have been well documented, whereas data on cellular immunity in humans are sparse. It is generally thought that two outer capsid proteins VP4 and VP7 play a critical role in protective immunity by stimulating production of neutralizing antibodies. While serotype- specific protection mediated by antibodies directed against the outer capsid proteins may be a mechanism of protection, such a correlate for protection has been difficult to demonstrate in humans during clinical trials. Increasing evidences suggest that viral proteins that lack a capacity of eliciting neutralizing antibody response also induce protective immunity. Limited efforts have focused on the role of non-structural proteins in protective immunity. This review describes current understanding of antibody responses in children with focus on responses specific to viral antigens with their possible role in protective immunity. We have also briefly reviewed the responses elicited to non-antibody effectors during RV infection in human subjects.


Subject(s)
Antibodies, Viral/blood , Child , Child, Preschool , Cytokines/immunology , Humans , Immunity, Innate/immunology , Immunoglobulin A/blood , Immunoglobulin G/blood , India , Rotavirus Infections/immunology , Rotavirus Vaccines/administration & dosage , T-Lymphocytes/immunology
2.
J Health Popul Nutr ; 2007 Mar; 25(1): 62-6
Article in English | IMSEAR | ID: sea-981

ABSTRACT

In a community-based double-blind randomized trial in children aged 6-35 months, both intervention and control groups received a multi-vitamin syrup containing vitamin A, while the intervention group had zinc gluconate (equivalent to 10 mg of elemental zinc) additional in the syrup. There was a significant decrease in diarrhoea and pneumonia in the intervention group. This study was undertaken to investigate if addition of zinc to vitamin A had improved plasma retinol levels, which, in turn, was responsible for the effects observed in the intervention group. In a randomly-selected subsample of 200 children--100 each from the intervention and the control group, plasma retinol levels after 120 days of supplementation were measured. There was no difference in the mean plasma retinol levels [the difference in the mean 0.46 microg/dL (95% confidence interval -1.42-2.36)] between the two groups following supplementation. No difference in plasma retinol levels was observed in the subgroups based on base-line nutritional status and plasma zinc levels. Addition of zinc to low-dose vitamin A in this study did not improve the vitamin A status of children and cannot explain morbidity effects of the intervention.


Subject(s)
Child Nutritional Physiological Phenomena , Child, Preschool , Diarrhea/epidemiology , Dietary Supplements , Double-Blind Method , Female , Humans , Infant , Male , Nutritional Status , Outcome Assessment, Health Care , Pneumonia/epidemiology , Trace Elements/administration & dosage , Vitamin A/administration & dosage , Vitamins/administration & dosage , Zinc/administration & dosage
3.
J Health Popul Nutr ; 2004 Sep; 22(3): 304-10
Article in English | IMSEAR | ID: sea-582

ABSTRACT

Data on the burden of disease, costs of illness, and cost-effectiveness of vaccines are needed to facilitate the use of available anti-typhoid vaccines in developing countries. This one-year prospective surveillance was carried out in an urban slum community in Delhi, India, to estimate the costs of illness for cases of typhoid fever. Ninety-eight culture-positive typhoid, 31 culture-positive paratyphoid, and 94 culture-negative cases with clinical typhoid syndrome were identified during the surveillance. Estimates of costs of illness were based on data collected through weekly interviews conducted at home for three months following diagnosis. Private costs included the sum of direct medical, direct non-medical, and indirect costs. Non-patient (public) costs included costs of outpatient visits, hospitalizations, laboratory tests, and medicines provided free of charge to the families. The mean cost per episode of blood culture-confirmed typhoid fever was 3,597 Indian Rupees (US$ 1=INR 35.5) (SD 5,833); hospitalization increased the costs by several folds (INR 18,131, SD 11,218, p<0.0001). The private and non-patient costs of illness were similar (INR 1,732, SD 1,589, and INR 1,865, SD 5,154 respectively, p=0.8095). The total private and non-patient ex-ante costs, i.e. expected annual losses for each individual, were higher for children aged 2-5 years (INR 154) than for those aged 5-19 years (INR 32), 0-2 year(s) (INR 25), and 19-40 years (INR 2). The study highlights the need for affordable typhoid vaccines efficacious at 2-5 years of age. Currently-available Vi vaccine is affordable but is unlikely to be efficacious in the first two years of life. Ways must be found to make Vi-conjugate vaccine, which is efficacious at this age, available to children of developing-countries.


Subject(s)
Adolescent , Adult , Anti-Bacterial Agents/therapeutic use , Child , Child, Preschool , Cohort Studies , Cost of Illness , Cost-Benefit Analysis , Female , Humans , Immunization Programs , India/epidemiology , Infant , Infant, Newborn , Male , Population Surveillance , Poverty Areas , Prospective Studies , Treatment Outcome , Typhoid Fever/drug therapy , Typhoid-Paratyphoid Vaccines , Urban Population
4.
J Health Popul Nutr ; 2004 Sep; 22(3): 311-21
Article in English | IMSEAR | ID: sea-912

ABSTRACT

Many economic analyses of immunization programmes focus on the benefits in terms of public-sector cost savings, but do not incorporate estimates of the private cost savings that individuals receive from vaccination. This paper considers the implications of Bahl et al.'s cost-of-illness estimates for typhoid immunization policy by examining how community-level incidence estimates and information on distribution of costs of illness among patients and the public-health sector can be used in the economic analysis of vaccination-programme options. The findings illustrate why typhoid vaccination programmes may often appear to be unattractive to public-health officials who adopt a public budgetary perspective. Under many plausible sets of assumptions, public-sector expenditure on typhoid vaccination does not yield comparable public-sector cost savings. If public-health officials adopt a societal perspective on the economic benefits of vaccination, there are many situations in which different vaccination programmes will make economic sense. The findings show that this is especially true when public decision-makers recognize that (a) the incidence of typhoid fever is underestimated by blood culture-positive cases and (b) avoided costs of illness represent a significant underestimate of the actual economic benefits to individuals of vaccination.


Subject(s)
Adolescent , Adult , Child , Child, Preschool , Cost of Illness , Cost-Benefit Analysis , Female , Humans , Immunization Programs/economics , India , Infant , Infant, Newborn , Male , Poverty Areas , Treatment Outcome , Typhoid Fever/economics , Typhoid-Paratyphoid Vaccines/economics , Urban Health
5.
Indian Pediatr ; 2003 May; 40(5): 463-76
Article in English | IMSEAR | ID: sea-10975
6.
J Health Popul Nutr ; 2002 Jun; 20(2): 148-55
Article in English | IMSEAR | ID: sea-624

ABSTRACT

The study aimed at obtaining insights into the processes underlying infant deaths to help identify preventive interventions which may bring down infant mortality rates further. Verbal autopsies were performed on 162 deaths of liveborn infants that occurred in a birth cohort in two urban slums of Delhi, India, between February 1995 and August 1996. A structured verbal autopsy form was used for ascertaining the cause of death. The narratives of caretakers on seeking of care and treatment received for illness were reviewed to identify the actions and behaviours that might have contributed to death. Seeking of care was less common (57%) for illnesses that led to death in the first week of life than at later ages. The first-week deaths commonly (61%) occurred within 24 hours of recognition of illness which might have been too a short time for effective interventions by care providers. Only six of 45 neonates who had features of sepsis, pneumonia or meningitis, major congenital malformations, birth asphyxia, or prematurity were advised by primary care providers for hospitalization. Similarly, only 25 (41%) of 61 older infants who had severe malnutrition and sepsis or meningitis, diarrhoea or pneumonia, or other illnesses were referred to hospital. Parenteral antibiotics were prescribed less often than warranted. Only two of 16 neonates with serious bacterial infections and eight of 19 postneonates with features of sepsis or meningitis received parenteral antibiotics. Inappropriate healthcare practices were common among the practitioners of modern and indigenous systems of medicine and registered medical practitioners. Forty percent of the neonates and a little over half of the older infants, advised for hospitalization, were taken to hospital. Fifteen percent of the infants taken to hospital were refused admission. Of 21 hospitalized infants discharged alive, five (23%) died within 48 hours and 13 (62%) within a week of returning home. A major effort is required to improve skills of healthcare providers of the biomedical and indigenous systems of medicine in caring for neonates and infants. Development of home-based treatment regimens for young infants and objective criteria for their hospitalization and discharge should receive a high priority.


Subject(s)
Age Factors , Cause of Death , Cohort Studies , Female , Hospitalization/statistics & numerical data , Humans , India/epidemiology , Infant , Infant Mortality , Infant, Newborn , Male , Patient Acceptance of Health Care/statistics & numerical data , Poverty Areas , Quality of Health Care , Urban Health/statistics & numerical data
SELECTION OF CITATIONS
SEARCH DETAIL